Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation
Yunfeng Lin , Qian Li , Lihua Wang , Quanyi Guo , Shuyun Liu , Shihui Zhu , Yu Sun , Yujiang Fan , Yong Sun , Haihang Li , Xudong Tian , Delun Luo , Sirong Shi
International Journal of Oral Science ›› 2022, Vol. 14 ›› Issue (1) : 51
Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation
With the emergence of DNA nanotechnology in the 1980s, self-assembled DNA nanostructures have attracted considerable attention worldwide due to their inherent biocompatibility, unsurpassed programmability, and versatile functions. Especially promising nanostructures are tetrahedral framework nucleic acids (tFNAs), first proposed by Turberfield with the use of a one-step annealing approach. Benefiting from their various merits, such as simple synthesis, high reproducibility, structural stability, cellular internalization, tissue permeability, and editable functionality, tFNAs have been widely applied in the biomedical field as three-dimensional DNA nanomaterials. Surprisingly, tFNAs exhibit positive effects on cellular biological behaviors and tissue regeneration, which may be used to treat inflammatory and degenerative diseases. According to their intended application and carrying capacity, tFNAs could carry functional nucleic acids or therapeutic molecules through extended sequences, sticky-end hybridization, intercalation, and encapsulation based on the Watson and Crick principle. Additionally, dynamic tFNAs also have potential applications in controlled and targeted therapies. This review summarized the latest progress in pure/modified/dynamic tFNAs and demonstrated their regenerative medicine applications. These applications include promoting the regeneration of the bone, cartilage, nerve, skin, vasculature, or muscle and treating diseases such as bone defects, neurological disorders, joint-related inflammatory diseases, periodontitis, and immune diseases.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
Goodman, R. P., Berry, R. M. & Turberfield, A. J. The single-step synthesis of a DNA tetrahedron. Chem. Commun. 12, 1372–1373 (2004). |
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
Fu, W. et al. Therapeutic siCCR2 loaded by tetrahedral framework DNA nanorobotics in therapy for intracranial hemorrhage. Adv. Funct. Mater. 31, https://doi.org/10.1002/adfm.202101435 (2021). |
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
Gao, Y., Zhang, T., Zhu, J., Xiao, D. & Cai, X. Effects of tetrahedral framework nucleic acids on myoblasts activity and skeletal muscle regeneration. Mater. Chem. Front. 4, 2731–43 (2020). |
| [84] |
|
| [85] |
Ma, W. et al. DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway. Cell Prolif. 51, e12503 (2018). |
| [86] |
|
| [87] |
|
| [88] |
Shi, S. et al. Modulation of chondrocyte motility by tetrahedral DNA nanostructures. Cell Prolif. 50, e12368 (2017). |
| [89] |
Lfa, B. et al. Tetrahedral framework nucleic acids promote the biological functions and related mechanism of synovium-derived mesenchymal stem cells and show improved articular cartilage regeneration activity in situ—ScienceDirect. Bioact. Mater. 9, 411–427 (2021). |
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
Chen, R. et al. Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage. Cell Prolif. 55, e13206 (2022). |
| [105] |
Zhang, T., Tian, T. & Lin, Y. Functionalizing framework nucleic-acid-based nanostructures for biomedical application. Adv. Mater. e2107820, https://doi.org/10.1002/adma.202107820 (2021). |
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
Ma, W., Zhan, Y., Zhang, Y., Shao, X. & Lin, Y. J. N. L. An intelligent DNA nanorobot with in vitro enhanced protein lysosomal degradation of HER2. 19, 4505-4517 (2019). |
| [111] |
Ma, W. et al. Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer. Adv. Mater. e2109609, https://doi.org/10.1002/adma.202109609 (2022). |
| [112] |
Shi, S. et al. Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel Nanoconjugates that can pass the blood brain barrier. Nanomedicine 21, 102061 (2019). |
| [113] |
Wei, M. et al. Tetrahedral DNA nanostructures functionalized by multivalent microRNA132 antisense oligonucleotides promote the differentiation of mouse embryonic stem cells into dopaminergic neurons—ScienceDirect. Nanomedicine 34, 102375 (2021). |
| [114] |
|
| [115] |
|
| [116] |
Hui, X. et al. Infrared plasmonic biosensor with tetrahedral DNA nanostructure as carriers for label-free and ultrasensitive detection of miR-155. Adv. Sci. 8, 2100583 (2021). |
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
Kim, K. R., Jegal, H., Kim, J. & Ahn, D. R. A self-assembled DNA tetrahedron as a carrier for in vivo liver-specific delivery of siRNA. Biomater. Sci. 8, 586–590 (2020). |
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
|
| [136] |
|
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
Yiqiao, T., Yanyu, H., Pan, G. & Tianfeng, C. Nucleus-targeted DNA tetrahedron as a nanocarrier of metal complexes for enhanced glioma therapy. Chem Commun. 54, 10.1039.C1038CC04021D (2018). |
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
|
| [157] |
|
| [158] |
|
| [159] |
|
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
|
| [164] |
|
| [165] |
|
| [166] |
|
| [167] |
|
| [168] |
|
| [169] |
|
| [170] |
|
| [171] |
|
| [172] |
|
| [173] |
|
| [174] |
|
| [175] |
|
| [176] |
|
| [177] |
|
| [178] |
|
| [179] |
|
| [180] |
|
| [181] |
|
| [182] |
|
| [183] |
Goonoo, N. Vascularization and angiogenesis in electrospun tissue engineered constructs: towards the creation of long-term functional networks. Biomed. Phys. Eng. Express 4, 032001 (2018). |
| [184] |
|
| [185] |
|
| [186] |
|
| [187] |
|
| [188] |
|
| [189] |
|
| [190] |
|
| [191] |
|
| [192] |
Kuperman, S. et al. Examination of the therapeutic potential of mouse oral mucosa stem cells in a wound-healing diabetic mice model. Int. J. Environ. Res. Public Health. 17, 4854 (2020). |
| [193] |
|
| [194] |
|
| [195] |
|
| [196] |
|
| [197] |
Gao, Y. Effects of the tetrahedral framework nucleic acids on the skeletal muscle regeneration in vitro and in vivo. Mater. Chem. Front. 4, 2731–2743 (2020). |
| [198] |
|
| [199] |
|
| [200] |
|
| [201] |
|
| [202] |
|
| [203] |
|
| [204] |
|
| [205] |
|
| [206] |
|
| [207] |
|
| [208] |
|
| [209] |
|
| [210] |
|
| [211] |
|
| [212] |
|
| [213] |
|
| [214] |
|
| [215] |
|
| [216] |
|
| [217] |
|
| [218] |
|
| [219] |
|
| [220] |
|
/
| 〈 |
|
〉 |